News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG Molecular Diagnostics to Hold 2017 First Quarter Results Conference Call on May 15, 2017
TUCSON, Ariz. , May 01, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that the Company will release 2017 first quarter results after market close on Monday, May 15,
View HTML
Toggle Summary HTG Molecular Diagnostics and Instituto Valenciano de Oncología Initiate Breast Cancer Recurrence Risk Collaboration
TUCSON, Ariz. , April 24, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a research collaboration agreement with Instituto Valenciano de Oncología
View HTML
Toggle Summary HTG Molecular Diagnostics Transfers Listing to The Nasdaq Capital Market
TUCSON, Ariz. , April 17, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that, on April 12, 2017, the company received formal notice from The NASDAQ Stock Market LLC indicating
View HTML
Toggle Summary HTG Molecular Diagnostics and Centre Léon Bérard Enter Into Molecular Profiling Research Agreement
TUCSON, Ariz. , April 17, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, announced that it has entered into a research agreement with Centre Léon Bérard, which provides the framework
View HTML
Toggle Summary HTG Molecular Diagnostics and Daiichi Sankyo Complete Master Services Agreement
TUCSON, Ariz. , April 17, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a master services agreement with Daiichi Sankyo Company, Limited ( Daiichi
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results
TUCSON, Ariz. , March 23, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today reported financial results for the fourth quarter and year ended December 31, 2016.
View HTML
Toggle Summary HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN GeneReader NGS System
TUCSON, Ariz. , March 23, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, today announced that its HTG EdgeSeq technology has been successfully adapted for use with the QIAGEN
View HTML
Toggle Summary HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU
TUCSON, Ariz. , March 22, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has obtained CE marking in the European Union for its HTG EdgeSeq ALK Plus Assay EU.
View HTML
Toggle Summary HTG Molecular Diagnostics to Hold 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 23, 2017
TUCSON, Ariz. , March 21, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, today announced that the Company will release 2016 fourth quarter and full year financial results after
View HTML
Toggle Summary HTG Molecular Diagnostics Appoints New Chair of the Board of Directors
Dr. Ann F. Hanham to Lead HTG’s Board of Directors TUCSON, Ariz. , March 07, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that Ann F.
View HTML